Clinical Trial Update: A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating QL1706 in combination with platinum-containing chemotherapy as adjuvant therapy for stage II-IIIB non-small cell lung can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Platinum-containing chemotherapy
• QL1706

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: RECRUITING